Given the high incidence of colorectal cancer (CRC), and the availability of procedures that can detect disease and remove precancerous lesions, there is a need for a model that estimates the probability of developing CRC across various age intervals and risk factor profiles.
INTRODUCTION
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the third leading cause of cancer death in the United States. During 2008, an estimated 148,810 new cases of CRC will be diagnosed, and 49,960 persons will die as a result of the disease. 1 Approximately one in 18 persons in the United States will develop CRC during his or her life.
Currently, several CRC screening strategies are available, including the fecal occult blood test (FOBT), double-contrast barium enema, flexible sigmoidoscopy, colonoscopy, virtual colonography, and combinations of these tests. Many of these strategies have been shown to be effective for reducing CRC incidence and mortality. 2, 3 Given the high incidence of CRC, its significant cost to society, and the availability of screening tests, a model that estimates an individual's probability of developing CRC using risk factor information that can be obtained easily in a clinical setting may aid physicians and their patients in deciding on screening regimens, and can also be useful in designing chemoprevention and screening intervention trials. 4 Several risk and protective factors for CRC have been consistently identified in epidemiologic studies, including physical activity, cigarette smoking, and body mass index (BMI). 5, 6 However, no quantitative risk model that takes competing causes of death into account is currently available to estimate the absolute risk or probability of developing CRC. Existing models are qualitative and based on expert opinion, 7 or applicable only to special populations. [8] [9] [10] We present a model that, given a set of risk and protective factors and age, predicts the absolute risk of developing CRC over a given time period, accounting for competing causes of death. We used data from two population-based case-control studies to assess risk or protective factors. After describing the study populations, we describe the development of the CRC absolute risk model and give examples of risk estimates for various combinations of factors. We also present a short, self-administered risk assessment questionnaire that can be used to obtain information about risk factors for the model.
METHODS

Study Populations Used to Estimate Relative Risk
We used data from two population-based case-control studies, one for colon cancer [11] [12] [13] and one for rectal cancer, [14] [15] [16] to estimate relative risks (RRs) of CRC. Controls for both case-control studies were matched to cases on sex and 5-year age groups. These studies were conducted by investigators at the Universities of Utah (Salt Lake City, UT), Minnesota (Minneapolis, MN), and the Kaiser Permanente Medical Care Program (KPMCP) of Northern California (Oakland, CA). The Appendix (online only) provides additional details.
We restricted our analyses to non-Hispanic white men and women age 50 years and older, who comprised the majority of participants in both studies. We differentiated proximal (cecum through transverse colon), distal (splenic flexure, descending, and sigmoid colon), and rectal (rectosigmoid junction and rectum) tumor sites because incidence rates for these sites differ dramatically by age, and because risk factors and prior screening may have different effects on each site (Fig 1) .
Risk Factors to Estimate RR Models
We assessed a variety of factors that have been consistently associated with colon or rectal cancer, 6,17,18 including age; history of CRC in first-degree relatives; history of sigmoidoscopy and/or colonoscopy; history of polyps; use of multivitamins; red meat, vegetable, and fruit consumption; alcohol intake; BMI (kg/m 2 ); cigarette smoking; use of aspirin and other nonsteroidal antiinflammatory drugs (NSAIDs); current leisure-time vigorous activity; and estrogen status as assessed by menopausal status and hormone-replacement therapy (HRT) use. Although additional nutrient variables including calcium, dietary fiber, and iron have been related to CRC risk in some studies, 6 ,18 a detailed dietary assessment and supporting nutrient database would be needed to capture these intakes accurately, making such an assessment unfeasible in most clinical settings. Therefore, we did not include dietary variables that require a detailed assessment. The Appendix includes further description of the variables we evaluated in developing our RR models.
Projecting Probabilities (absolute risk) of Developing CRC
Our approach 19 included (1) estimating RR parameters from populationbased case-control data separately for proximal, distal, and rectal cancer; (2) estimating baseline age-specific cancer hazard rates (based on the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) Program incidence rates) and attributable risks (ARs) from the case-control data; and (3) combining competing risks, RRs, and baseline hazards to estimate the probability of developing the first of proximal, distal, or rectal cancer over a prespecified time interval (eg, 5, 10, or 20 years) given a person's age and risk factors. The advantage of modeling the sites separately is that the covariates have different associations by various sites, and thus discriminatory accuracy can be improved by separately modeling each site. 20 The Appendix contains additional details.
Estimating the RR Models
We analyzed proximal and distal colon cancer cases separately and used all eligible controls from the colon cancer study [11] [12] [13] to estimate separate RR models. Age was included in the models in two categories (Յ 65 and Ͼ 65) when significant, to account for the matching. We determined RR estimates for all factors described earlier herein and assessed interactions among these factors and with age. Because a substantial number of participants in both studies had missing information on sigmoidoscopy/colonoscopy, we included an "unknown" category for that variable in all models. The following variables were coded as 0, 1, 2 for one df (trend) models: men proximal-smoking, BMI and family history; men distal-BMI and family history; men rectal-current vigorous exercise; women proximal-current vigorous exercise and family history; and women distal-family history. Odds ratios (ORs) estimating RRs and corresponding 95% CIs were computed from unconditional logistic regression models. Variable selection for inclusion in the final model was based on Wald tests for individual parameters as well as information on previously established risk factors. Statistical analyses were performed using SAS software (version 8.2; SAS Institute Inc, Cary, NC).
Estimating the Baseline Age-Specific CRC Hazard Rates
The baseline hazard rate was defined as the hazard rate for individuals each of whose risk factors are at the lowest risk level. The age-specific baseline hazard rates were computed by multiplying the age-specific SEER incidence rates by 1 -[the estimate of the AR for each CRC cancer site] 19 (Appendix). The age-and sex-specific SEER incidence rates for proximal, distal, and rectal cancer (Appendix) were obtained for white non-Hispanics in 13 SEER registries between 1992 and 2002 that cover 14% of the US population.
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Cancers of the appendix, second primary, and recurrence of colorectal cancers were not included in the computation of these rates. Competing mortality hazards from causes other than CRC were obtained from US mortality data between 1990 and 2002 (Appendix).
CIs on the Absolute Risk Estimates
We extended the influence function method of Graubard and Fears, 22 for the three outcomes (proximal, distal, or rectal cancer) to estimate the variance of the absolute risk estimate (Appendix). Approximate normality of the estimates was used to obtain 95% CIs for the estimated absolute risks.
Risk Assessment Questionnaire
We constructed a short, self-administered risk assessment questionnaire to capture the information used in the CRC risk prediction models. We tested Cases per 100,000
Age (years) 
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www.jco.org the questionnaire using cognitive interviewing techniques. 23 Cognitive interviews involved four "rounds" of nine participants each. We used verbal probing and think-aloud techniques to evaluate sources of misunderstanding and inaccuracy in reporting. Based on the results of our cognitive testing, the questionnaire was improved after each round to address potential sources of response errors 24 and until it was usually understandable and yielded responses that appeared to classify individuals into risk categories accurately.
RESULTS
RR Models
In our analyses, we included 1,599 colon cancer cases (665 men, 708 women) with 1,974 controls (1,058 men, 916 women) and 664 rectal cancer cases (397 men, 267 women) with 859 controls (478 men, 381 women). Table 1 displays frequencies for age and recruitment site for men and women respectively, and for proximal, distal, and rectal tumor sites.
Several factors were not related to CRC risk in our data, including FOBT; multivitamin use; alcohol use; and red meat and fruit consumption. We examined variables for smoking status and smoking pack-years for each risk model, but included only the variables "smoking duration and usual number of cigarettes smoked per day for current and former smokers" when significant, because this variable seemed to have the strongest effect of all the smoking variables, as noted previously in these studies. 25 For men, the predictors of proximal colon cancer in the final model were prior negative sigmoidoscopy and/or colonoscopy, polyp history, number of relatives with CRC, aspirin and NSAID use, usual number of cigarettes smoked per day and years of smoking in current and former smokers, BMI, and servings of vegetables per day (Table  2) . For example, men with two or more first-degree relatives with CRC were more likely to be diagnosed with proximal colon cancer than those without a positive family history (OR ϭ 3.28; 95% CI, 1.84 to 5.84), whereas regular users of aspirin or NSAIDS were less likely to be diagnosed with proximal colon cancer (OR ϭ 0.65; 95% CI, 0.51 to 0.82). For distal colon cancer, the final model included the same factors except for smoking and vegetable consumption ( Table 2 ). The RR model for rectal cancer included sigmoidoscopy and/or colonoscopy, polyp history, number of relatives with CRC, NSAID use, and current vigorous leisure-time activity (Table 2) . Only four controls and two cases in the rectal case-control study reported having two or more family members with CRC; therefore, family history was incorporated into the rectal RR model as "one or more relatives with CRC." None of the models showed significant two-way interactions among these variables. All three RR models for men included separate intercepts for study center.
For women, the proximal colon RR model included prior negative sigmoidoscopy and/or colonoscopy, polyp history, number of relatives with CRC, estrogen status within the last 2 years, current vigorous activity, aspirin and NSAID use, and servings of vegetables per day (Table 3 ). The distal colon RR model included sigmoidoscopy and/or colonoscopy and polyp history, number of relatives with CRC, aspirin and NSAID use, and estrogen status within the last 2 years, an age indicator (Ն 65 years), BMI, and an interaction between BMI and estrogen status ( vigorous leisure-time activity, aspirin and NSAID use, and BMI were all included in the rectal cancer RR model for women (Table  3) . Again, because of small numbers in the rectal RR model, family history of colorectal cancer was reduced to "one or more relatives with CRC." All three RR models for women included separate intercepts for study center.
Estimates of the Baseline Age-Specific CRC Hazard Rates
To compute baseline hazard rates, we estimated separate ARs for the three models for men and women. Because the ARs did not differ by study site, we obtained combined AR estimates separately for proximal, distal and rectal cancer. The AR estimates for men were 0.86 (95% CI, 0.79 to 0.91) for proximal, 0.72 (95% CI, 0.63 to 0.80) for distal, and 0.90 (95% CI, 0.69 to 0.97) for rectal cancer. For women, the AR estimates were 0.81 (95% CI, 0.69 to 0.90) for proximal, 0.82 (95% CI, 0.73 to 0.89) for distal in women younger than 65 years, 0.85 (95% CI, 0.76 to 0.91) for distal in women age 65 years or older, and 0.93 (95% CI, 0.57 to 0.99) for rectal cancer. Table 4 presents estimates of the 10-and 20-year projected absolute risks of developing CRC for white men with various ages and risk factor profiles. The first risk profile, the lowest risk example, describes a 50-year-old man who had a colonoscopy in the last 10 years without evidence of polyps. He has no family history of CRC, vigorously exercises 5 hours/week, takes aspirin daily, never smoked, eats more than five servings of vegetables/day, and has a BMI of 24 kg/m 2 . His 10-year predicted absolute risk of developing CRC is only 0.16% (95% CI, 0.11 to 0.22), and his 20-year risk is 0.53% (95% CI, 0.38 to 0.73). In risk profile 9, a high-risk example, we consider a 60-year-old man who had a colonoscopy in the last 10 years and was found to have a polyp. He has two relatives with CRC, does not exercise regularly, does not take aspirin or NSAIDS regularly, smokes more than 20 cigarettes a day, eats fewer than five servings of vegetables per day, and has a BMI of 31 kg/m 2 . His 10-year predicted absolute risk of developing CRC is 7.14% (95% CI, 3.9 to 12.8), and his 20-year risk is 16.7% (95% CI, 9.1 to 28.5). Similar 10-and 20-year projected absolute risks of developing CRC for white women with various ages and risk factor profiles are presented in Table 5 .
Examples of Individual Absolute Risk Estimates for CRC
Risk Assessment Questionnaire
The short, paper-based, self-administered risk assessment questionnaire we constructed to capture the information required by the models (Tables 2 and 3 ) requires 5 to 8 minutes to complete. A Web version of the questionnaire is available at http//www.cancer.gov/ colorectalcancerrisk/.
DISCUSSION
We present a model that predicts the probability or absolute risk of developing CRC for men and women age 50 years and older. We combined separate RRs and ARs and baseline hazards for proximal, distal, and rectal cancers to project the risk of the earliest of these tumors. We also developed a short, simple, self-administered risk assessment questionnaire that can be used to obtain information for risk estimation.
In related work, we used independent data from the National Institutes of Health (NIH)-AARP Diet and Health Cohort Study 26 of men and women age 55 years and older to assess the performance of our models. 27 We found that the models had discriminatory accuracy comparable with absolute risk models for other cancers and were well calibrated.
Although the models were developed from cases and controls age 50 years and older, one could project risk for younger individuals by assuming that our relative and ARs apply to younger populations and by using younger age-specific SEER rates. However, such assumptions would need to be checked in independent data because risk factors and biologic mechanisms may differ among those developing CRC at younger ages.
Although absolute risk models exist for breast cancer and lung cancer, 19, 28 this is the first such model for CRC. The four other CRC risk prediction models currently available either apply to special populations, such as patients who were referred by general practitioners to gastroenterologists for symptoms, 8 provide a qualitative index of CRC risk, 7, 10 or predict different outcomes, such as the risk of having an advanced polyp or cancer in the proximal portion of the colon. 9 Our model estimates the probability of developing CRC over a prespecified time interval from data collected from two large US population-based case-control studies of colon and rectal cancer, incidence data from 13 SEER registries, which are generally representative of the US population 29 and from national mortality rates. Thus, our risk prediction models would be expected to apply to the general non-Hispanic white US population. We used factors in our models that, in addition to having strong predictive ability, can also be ascertained easily in a clinical setting. Thus, we did not include some factors that may have predictive value, such as and calcium intake or long-term vigorous activity 30-33 but which would require a much more complex questionnaire.
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Our risk prediction model has some limitations. Because the majority of participants in the case-control studies were white, we could not estimate RRs for other racial or ethnic groups. A first step to developing models for other racial/ethnic groups could be to combine RR and AR estimates for whites with SEER rates for blacks, Asians, or Hispanics. However, the assumption of constant AR and RR estimates across racial groups needs to be validated in minority populations. Our model is not applicable to individuals with ulcerative colitis, Crohn's disease and familial adenomatous polyposis, because these conditions carry a high risk of CRC, and individuals with these conditions were excluded from the studies. Additionally, our model is not applicable to individuals with hereditary nonpolyposis CRC.
Because we used US mortality data from 1990 to 2002 for our competing mortality hazards, we did not adjust these estimates for potential confounders such as BMI given that our sensitivity analyses NOTE. Categories for each variables used in the CRC absolute risk model: sigmoidoscopy and/or colonoscopy and polyp history in the last 10 years-no, sigmoidoscopy and/or colonoscopy; yes, sigmoidoscopy and/or colonoscopy, no polyps; yes, sigmoidoscopy and/or colonoscopy, yes polyps; unknown sigmoidoscopy and/or colonoscopy and polyps. Number of relatives with CRC-0, no relatives; 1 relative; Ն 2 relatives. Current leisure-time activity-0 h/wk; 0 to 2 h/wk; 2 to 4 h/wk; Ͼ 4 h/wk. Regular user of aspirin/NSAIDs-regular user, at least 3 times/wk; nonuser, less than 3 times/wk. Vegetable intake-Ͻ 5 servings/d; 5ϩ servings/d. Body mass index-underweight and normal weight Ͻ 30 kg/m 2 ; overweight Ն 30 kg/mindicated that changes in the risk estimates were small (data not shown). Although our two case-control studies were conducted at slightly different time periods, we believe any changes in the distribution of risk factors would have a minimal effect on our risk estimates, considering that RRs and ARs were estimated separately for the two studies.
Another limitation of our model is that we estimated our RRs and ARs from case-control rather than from cohort studies. Although case-control studies have been used in the development of risk prediction models for melanoma, 35 breast, 19, 36, 37 bladder, 38 and lung cancer, 39 a general criticism is that such estimates could be subject to recall bias. However, recall bias likely plays a minor role in our models as most of the RRs we found, including BMI, physical activity, HRT, and aspirin and NSAIDs use, were consistent with RRs summarized in a recent comprehensive review of the epidemiologic literature. 6 Although not covered in this review, our risk estimates for screening and polyp history, 2,40,41 smoking, 42 and family history 43, 44 are also consistent with many previously published findings, including results from cohort studies. Additionally, the models were well calibrated in an independent validation study using the AARP cohort.
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In summary, we developed an absolute CRC risk projection model for white men and women age 50 years or older that may aid physicians and their patients in deciding on screening regimens, and can also be useful in designing chemoprevention and screening intervention trials.
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